fda - Search News

FDA, Recalled ice cream

Recalled ice cream sold nationwide could contain small stones, FDA says

A New York-based food company is voluntarily recalling nondairy ice cream sold nationwide because it may contain foreign materials, including "small stones," according to the U.S. Food and Drug Administration (FDA).

· 23h · on MSN

FDA announces recall of frozen dessert pints over possible 'small stones'

· 1d · on MSN

This recalled ice cream could contain small stones. What to know.

FDA, infant formula and recall

Digest more

· 6h · on MSN

FDA warns retailers that failed to pull recalled baby formula

The U.S. Food and Drug Administration sent warning letters to retailers after investigators found they continued selling recalled infant formula.

· 1d · on MSN

FDA says retailers didn't remove recalled formula fast enough

· 1d · on MSN

FDA warns Target, Walmart for selling baby formula linked to botulism

· 2d

FDA sends warning letters to major retailers for selling recalled formula linked to infant botulism outbreak

The US Food and Drug Administration sent warning letters to Target, Walmart, Kroger and Albertsons after some of the stores failed to remove recalled baby formula linked to a large infant botulism out...

· 1d

FDA sends warning to retailers still selling recalled baby formula linked to botulism

ConsumerAffairs · 1d

FDA warns Walmart, Target and Kroger over recalled baby formula still on shelves

abc7NY · 1d

FDA sends warning letters to retailers for selling recalled baby formula linked to botulism outbreak

Checking stores more than 4,000 times, inspectors found the recalled products in over 175 locations across 36 states, according to the

· 1d

America’s largest chains accused of failing to pull botulism-linked baby formula fast enough

Journal Record · 1d

FDA sends warning letters to Walmart, Target for selling recalled baby formula

MedPage Today on MSN

FDA's $250K Travel Bill; Q&A With Retsef Levi; Staffers Air Hoeg Concerns

Retsef Levi, PhD, who teaches operations management and healthcare decision-making at MIT and is not a physician, was appointed to the Advisory Committee on Immunization Practices (ACIP) during HHS Secretary Robert F. Kennedy Jr.'s overhaul of the panel.

1don MSN

FDA approves label change for Depo-Provera, adding brain tumor warning

Pfizer faces a lawsuit in which women allege the drugmaker failed to warn them about the risks of meningioma associated with the birth control shot.

FDA commissioner on growing public mistrust of government health advice

FDA Commissioner Martin Makary discusses vaccine policy, COVID-era decisions and the erosion of trust in government health guidance.

2don MSN

AstraZeneca, Daiichi's breast cancer drug gets FDA nod as first-line treatment

The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's Enhertu in combination with Roche's drug, Perjeta, for the first-line treatment of patients with a type of breast cancer,

2don MSN

FDA says it may relax warning label rule for dietary supplements

Supplements aren’t reviewed for safety and effectiveness, but disclaimers about health benefits are required on products.

Fierce Pharma

Novo gets FDA warning letter at troubled Indiana site formerly owned by Catalent

Novo Nordisk, which has stumbled through a bit of a manufacturing hangover at a former Catalent production site it

Everyday Health on MSN

FDA Approves First Pill to Boost Sex Drive in Women After Menopause

Addyi (flibanserin) was cleared a decade ago to treat low sex drive in women before menopause. A new FDA action allows treatment through age 65.

Exclusive-US FDA taps Merck drugs with blockbuster sales potential for national priority vouchers

Food and Drug Administration is moving to fast-track reviews of two experimental Merck drugs with multibillion-dollar potential, according to internal documents seen by Reuters. Merck's cholesterol pill enlicitide decanoate and its cancer therapy sacituzumab tirumotecan,